Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy

Published:2013-04-22 Issue:5 Volume:4 Page:483-491
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Kim Jin Taek¹,Kim Sang Soo²,Jun Dae Won³,Hwang Young Hwan¹,Park Wook-Ha⁴,Pak Youngmi Kim⁴,Lee Hong Kyu¹

Affiliation:

1. Department of Internal Medicine; College of Medicine; Eulji University; Seoul Korea

2. Eulji Medi-Bio Research Institute; Seoul Korea

3. Department of Internal Medicine; College of Medicine; Hanyang University; Seoul Korea

4. Department of Physiology; College of Medicine; Kyung Hee University; Seoul Korea

Funder

Eulji Medi-Bio Research Institute

Korean Ministry of Knowledge and Economy

Korean Ministry of Education, Science, and Technology

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12081/fullpdf

Reference44 articles.

1. Diabetic microvascular complications: can patients at risk be identified? A review;Girach;Int J Clin Pract,2006

2. Similar risks of nephropathy in patients with type I or type II diabetes mellitus;Hasslacher;Nephrol Dial Transplant,1989

3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

5. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002;Lee;Diabetes Care,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation;Frontiers in Pharmacology;2024-08-22

2. Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis;Acta Diabetologica;2024-05-01

3. Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor;Cellular & Molecular Biology Letters;2024-03-15

4. The Effect of DNA Methylation in the Development and Progression of Chronic Kidney Disease in the General Population: An Epigenome-Wide Association Study Using the Korean Genome and Epidemiology Study Database;Genes;2023-07-21

5. Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development;Cellular & Molecular Biology Letters;2022-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3